STYLUS MEDICINE
Summary
Stylus Medicine is a developing transformative in vivo genetic medicines to unlock cures.
Deals Overview
Total Deals1
Valued Deals1
Total Value£ 64 M
Avg. Deal Size£ 64 M
All rights reserved. Copyright © 2025 Datasite
Summary
Stylus Medicine is a developing transformative in vivo genetic medicines to unlock cures.
Deals Overview
All rights reserved. Copyright © 2025 Datasite
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
Senior Management
Emile Nuwaysir
Chairman and Chief Executive Officer
Jason Fontenot
Chief Scientific Officer
Patrick Hsu
Scientific Founder